CAH 📈 Cardinal Health - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14149Y1082

CAH: Pharmaceuticals, Medical Supplies, Surgical Products, Gloves, Needles, Syringes

Cardinal Health Inc, a multinational healthcare services and products company, operates across the globe, with a presence in the United States, Canada, Europe, Asia, and other international markets. The company provides tailored solutions to a diverse range of customers, including hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients receiving care in their homes. By offering a broad portfolio of products and services, Cardinal Health aims to improve the efficiency and effectiveness of healthcare delivery.

The company's operations are organized into two primary segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The Pharmaceutical and Specialty Solutions segment focuses on distributing a wide range of pharmaceutical products, including branded and generic medications, specialty pharmaceuticals, and over-the-counter healthcare and consumer products. Additionally, this segment provides specialized services to pharmaceutical manufacturers and healthcare providers, such as pharmacy management services for hospitals and repackaging of generic pharmaceuticals and over-the-counter healthcare products.

In the Global Medical Products and Distribution segment, Cardinal Health manufactures, sources, and distributes a vast array of medical, surgical, and laboratory products, including exam and surgical gloves, needles, syringes, and sharps disposals. The company also offers a range of compression, incontinence, nutritional delivery, and wound care products, as well as single-use surgical drapes, gowns, and apparel products. Furthermore, Cardinal Health distributes national brand products, provides supply chain services and solutions to healthcare providers, and assembles and sells sterile and non-sterile procedure kits.

Cardinal Health's product portfolio is complemented by its radiopharmaceutical manufacturing, preparation, delivery, and distribution capabilities, which cater to the needs of healthcare providers and patients. The company also leverages integrated technology solutions to optimize direct shipments and streamline its logistics operations. With a history dating back to 1979, Cardinal Health is headquartered in Dublin, Ohio, and has established itself as a leading player in the healthcare distribution industry, with a strong online presence at https://www.cardinalhealth.com.

As a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol CAH, Cardinal Health's common stock is classified under the GICS Sub Industry of Health Care Distributors, with the ISIN code US14149Y1082. This classification reflects the company's core business activities and its position within the broader healthcare industry. By providing a wide range of products and services to healthcare providers and patients, Cardinal Health plays a critical role in supporting the delivery of high-quality patient care.

Additional Sources for CAH Stock

CAH Stock Overview

Market Cap in USD 28,952m
Sector Healthcare
Industry Medical Distribution
GiC Sub-Industry Health Care Distributors
IPO / Inception 1987-12-31

CAH Stock Ratings

Growth 5y 91.6%
Fundamental 41.2%
Dividend 48.0%
Rel. Strength Industry 446
Analysts 3.65/5
Fair Price Momentum 135.68 USD
Fair Price DCF 113.42 USD

CAH Dividends

Dividend Yield 12m 1.63%
Yield on Cost 5y 4.34%
Annual Growth 5y -4.84%
Payout Consistency 95.3%

CAH Growth Ratios

Growth Correlation 3m 53.1%
Growth Correlation 12m 59%
Growth Correlation 5y 92.6%
CAGR 5y 21.65%
CAGR/Mean DD 5y 2.67
Sharpe Ratio 12m 0.70
Alpha 0.38
Beta 0.71
Volatility 24.21%
Current Volume 2375.9k
Average Volume 20d 2177.3k
What is the price of CAH stocks?
As of January 15, 2025, the stock is trading at USD 124.03 with a total of 2,375,868 shares traded.
Over the past week, the price has changed by +1.03%, over one month by +2.78%, over three months by +8.45% and over the past year by +15.73%.
Is Cardinal Health a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Cardinal Health (NYSE:CAH) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 41.19 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CAH as of January 2025 is 135.68. This means that CAH is currently overvalued and has a potential downside of 9.39%.
Is CAH a buy, sell or hold?
Cardinal Health has received a consensus analysts rating of 3.65. Therefor, it is recommend to hold CAH.
  • Strong Buy: 5
  • Buy: 2
  • Hold: 9
  • Sell: 1
  • Strong Sell: 0
What are the forecast for CAH stock price target?
According to ValueRays Forecast Model, CAH Cardinal Health will be worth about 148.2 in January 2026. The stock is currently trading at 124.03. This means that the stock has a potential upside of +19.45%.
Issuer Forecast Upside
Wallstreet Target Price 130.6 5.3%
Analysts Target Price 129.7 4.6%
ValueRay Target Price 148.2 19.5%